1. Home
  2. CRNC vs MRVI Comparison

CRNC vs MRVI Comparison

Compare CRNC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerence Inc.

CRNC

Cerence Inc.

HOLD

Current Price

$7.18

Market Cap

316.0M

Sector

Technology

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.07

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNC
MRVI
Founded
2020
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
316.0M
472.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
CRNC
MRVI
Price
$7.18
$3.07
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$11.50
$4.00
AVG Volume (30 Days)
669.7K
1.3M
Earning Date
05-04-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
96.95
14.29
EPS
N/A
N/A
Revenue
$251,781,000.00
$185,743,000.00
Revenue This Year
$27.17
$11.80
Revenue Next Year
N/A
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.94
$1.67
52 Week High
$13.74
$4.11

Technical Indicators

Market Signals
Indicator
CRNC
MRVI
Relative Strength Index (RSI) 35.44 39.04
Support Level $6.41 $2.88
Resistance Level $11.87 $3.99
Average True Range (ATR) 0.31 0.20
MACD 0.10 -0.05
Stochastic Oscillator 31.53 10.53

Price Performance

Historical Comparison
CRNC
MRVI

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: